11 |
Espectroscopia Raman aplicada ao estudo da resposta bioquímica de tecidos a compostos lamelares / Raman spectrocopy applied to the study of biochemical responses of tissues to lamellar compoundsOtávio Mendes Gil 14 August 2015 (has links)
Nesta Dissertação de Mestrado foram estudadas as respostas inflamatórias e de reparo de tecido muscular de ratos a implantes de hidróxidos duplos lamelares (HDL) contendo íon cloreto e sulindaco (fármaco anti-inflamatório não-esteroidal - FAINE) em seu espaço interlamelar. As técnicas empregadas nesta investigação foram as espectroscopias Raman e de absorção no infravermelho (FTIR), a difratometria de raios X (XRD) e a análise histomorfológica dos tecidos corados pelas técnicas de Hematoxilina e Eosina (HE) (Michalany, 1990)(Michalany, 1990)(Michalany, 1990) e Picrosirius Red (Picro). Simulações do espectro vibracional foram feitas por DFT usando o pacote computacional Gaussian 09 e as análises estatísticas foram feitas usando o pacote Unscrambler X.10.1. Os experimentos in vivo foram realizados fazendo-se a implantação das pastilhas de HDL por microcirurgia entre as camadas do músculo externo oblíquo de ratos (Wistar) e como experimento controle foi feita a separação de tais camadas simulando um implante. Os tecidos foram coletados após 7, 21, 28 e 35 dias de pós operatório, divididos em duas porções (uma para análise histomorfológica e outra para análise por espectroscopia Raman). Inicialmente foram feitos os cálculos teóricos e a caracterização espectroscópica do sulindaco, que possibilitou melhorar sua atribuição vibracional encontrada na literatura. O mesmo ocorreu com as matrizes de HDL, de Zn(II) e de Mg(II), intercaladas com íons cloreto, o que também resultou em um aprimoramento da atribuição que é encontrada na literatura. Os dois HDLs intercalados com sulindaco também foram caracterizados espectroscopicamente e os espectros Raman mostraram grande semelhança com a espécie do fármaco desprotonado. O difratograma obtido dos intercalatos mostra expansão do espaçamento basal (de 7 Å para 26 Å) compatível com a intercalação do sulindaco inclinado em relação ao plano das lamelas. Os espectros Raman do tecido controle mostram alterações mais significativas nas banda amida I e amida III com o tempo de pós-operatório e por PCA foi possivel observar a nítida separação do grupo que apresenta um processo inflamatório agudo (7 dias). Os tecidos expostos à pastilha de HDL intercalada com íons cloreto, mostraram resposta inflamatória reduzida em relação ao tecido controle e as alterações espectrais observadas evidenciam a presença de colágenos, o que indica uma aceitação da pastilha por parte do organismo (biocompatibilidade). As pastilhas também foram analisadas espectroscopicamente e mostraram que houve incorporação de íons CO32- no espaço interlamelar, indicado pela presença da banda Raman em 1060 cm-1 (estiramento simétrico C-O nesse íon), mas não foi possivel determinar se eventuais variações no pH local exerceram efeitos na resposta inflamatória. No caso dos tecidos expostos à pastilha de HDL com sulindaco, a análise por microscopia Raman mostrou que o processo inflamatório foi significativamente reduzido, evidenciando uma ação local do fármaco, além do crescimento de colágenos do tipo III. A pastilha de HDL com sulindaco implantado foi analisada por FT-Raman e a liberação do fármaco foi confirmada. Os resultados de espectroscopia Raman de tecidos foram confirmados pela análise histomorfológica, que mostrou haver de fato um acúmulo de colágeno do tipo III nas regiões próximas às pastilhas implantadas, assim como a formação de invaginações e neovascularização. / In this Master\'s Thesis the inflammatory responses and tissue repair of rat muscles caused by implants of Lamellar Double Hydroxides (LDH) containing chloride ion and sulindac (anti-inflammatory non-steroidal drug - NSAID) in its interlayer space was studied. The techniques used in this research were the Raman spectroscopy and infrared absorption spectroscopy (FTIR), the X-ray diffraction (XRD) and the histomorphological analysis of tissues stained by techniques of Hematoxylin and Eosin (HE) and Picrosirius Red (Picro). Simulations of vibrational spectrum were made by DFT using the computational package Gaussian 09 and the statistical analyzes were performed using the Unscrambler X.10.1 package. In vivo experiments were performed by making the implantation of HDL tablets by microsurgery between the layers of the external oblique muscle of rats (Wistar) and as a control experiment the separation of the layers to simulate an implant was conducted. The tissues were collected after 7, 21, 28 and 35 days postoperatively, divided into two parts (one for histomorphological analysis and the other for analysis by Raman spectroscopy). Initially, theoretical calculations and spectroscopic characterization of sulindac where made, which enabled improving its vibrational assignment in the literature. The same happened for the LDH matrices, Zn(II) and Mg(II), both with chloride ions in the interlamelar space, which also resulted in an improving of it vibrational assignment found in the literature. Both LDH intercalated with sulindac were also characterized spectroscopically and their Raman spectra showed great agreement to the deprotonated species of thedrug. The diffraction pattern obtained from intercalated compounds shows an expansion of the basal spacing (7 Å to 26 Å) compatible with the hypothesis of the sulindac inclined relative to the lamelar plane. The Raman spectra control tissues show the most significant changes in the band amide I and amide III after diferente surgery times and through PCA was possible to observe the clear separation of the group that presenting an acute inflammatory process (at 7 days). Tissues exposed to LDH pellet intercalated with chloride ions showed a reduced inflammatory response relative to control tissue and the spectral changes demonstrate the presence of collagen, which indicates an acceptance of the insert by the body (biocompatibility). The pellets were also analyzed spectroscopically and showed that there was incorporation of CO32- ions in the interlayer space, indicated by the presence of the Raman band at 1060 cm-1 (symmetric stretch C-O of this ion), but it was not possible to determine if changes in local pH affect the inflammatory response. In the case of tissues exposed to LDH tablet with sulindac, analysis by Raman microscopy showed that inflammation was significantly reduced, indicating a local action of the drug, in addition, the collagen type III growth has been observed. The implanted LDH pellet with sulindac was analyzed by FT-Raman and the drug release was confirmed. The results of Raman spectroscopy of tissues were confirmed by histomorphological analysis, which showed that there is indeed an accumulation of collagen type III in the tissue regions near to the implanted pellets, as well as the formation of invagination and neovacularization.
|
12 |
DEVELOPMENT OF INNOVATIVE MODIFIED-RELEASE LIQUID ORAL DOSAGE FORMSRonchi, Federica 08 September 2020 (has links) (PDF)
Modified-release oral drug delivery dosage forms are widely used in the pharmaceutical field to overcome all the potential issues imposed by the physiological variabilities of the gastrointestinal tract as well as to maintain drug concentrations within the therapeutic window. In the market, they are available only as solid dosage forms such as capsules or tablets. The development of a liquid oral dosage form with modified-release properties has been keenly awaited. This form could increase the compliance of patients with a swallowing impairment (i.e. paediatric, older or critically ill patients) and, consequently, the efficacy of the therapeutic treatment. In this study, a new technology has been developed that consists of multi-layered particles suspended extemporaneously in a syrup. Omeprazole and budesonide have been employed as model drugs. The coating procedure was optimized to obtain a yield of minimum 90% w/w and a median diameter below 500 µm. Once the final suspension is prepared extemporaneously, it presents sufficient stability to guarantee the administration of multiple doses filled into a syrup bottle and kept for a limited storage time at room temperature (e.g. up to 10 doses to be administered within 10 days). / Doctorat en Sciences biomédicales et pharmaceutiques (Pharmacie) / info:eu-repo/semantics/nonPublished
|
Page generated in 0.0238 seconds